Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Brainsway (BWAY) Stock Price & Analysis

2 Followers

BWAY Stock Chart & Stats

ILA 3,653.00ILA 164.00(4.70%)
At close:
ILA 3.5KILA 4KILA 4.5KILA 5KAug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
ILA 3,489.00 - ILA 3,699.00
52-Week Range
ILA 2,391.00 - ILA 5,165.00
Previous Close
ILA 3,489.00
Volume
N/A
Average Volume (3M)
77.96K
Market Cap
ILS 1.40B
Enterprise Value
ILS 1.68B
Total Cash (Recent Filing)
ILS 61.94M
Total Debt (Recent Filing)
ILS 7.13M
Price to Earnings (P/E)
45.4
Beta
0.64
Next Earnings
Nov 10, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Guidance

Strong recent growth and higher full-year guidance indicate expanding commercial traction rather than isolated quarterly performance. If execution continues, the larger revenue base can support operating leverage, strengthen market presence, and provide resources for further clinical and commercial investment over the next several quarters.

Installed Base And Recurring Revenue

A growing installed base can create durable revenue through continued system utilization, accessories, services, and leasing relationships. Rising placements also expand clinical presence and adoption opportunities, making future growth less dependent on selling entirely to new providers each quarter.

Strong Margins And Balance Sheet

High gross margins provide meaningful economic support for the business model, while substantial cash and no debt preserve financial flexibility. This combination can help fund clinical development, commercialization, and strategic initiatives without the refinancing pressure associated with heavier leverage.

Bears Say

Cash-Flow Volatility

Profit growth has not translated into consistently improving cash generation, creating a quality risk for the turnaround. Working-capital swings or higher cash costs could constrain internally funded expansion and make reported earnings less dependable as a guide to available financial resources.

Uneven Reimbursement Adoption

Uneven reimbursement can slow provider adoption even when clinical evidence is favorable, because clinics may hesitate to submit cases or invest in treatment capacity without predictable payment. This creates a structural risk to system placements, utilization, and recurring revenue growth across markets.

Rising Operating Expenses

Higher R&D and administrative spending may support future growth, but it also places continuing pressure on operating leverage and margins. If these costs rise faster than revenue or commercialization benefits take longer to arrive, profitability and cash generation could remain less consistent.

Brainsway News

BWAY FAQ

What was Brainsway’s price range in the past 12 months?
Brainsway lowest stock price was ILA 2391.00 and its highest was ILA 5165.00 in the past 12 months.
What is Brainsway’s market cap?
Brainsway’s market cap is ₪1.40B.
When is Brainsway’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Brainsway’s earnings last quarter?
Brainsway released its earnings results on Aug 12, 2026. The company reported ILA 20 earnings per share for the quarter.
Is Brainsway overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Brainsway pay dividends?
Brainsway does not currently pay dividends.
What is Brainsway’s EPS estimate?
Brainsway’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brainsway have?
Brainsway has 40,252,990 shares outstanding.
What happened to Brainsway’s price movement after its last earnings report?
Brainsway reported an EPS of ILA 20 in its last earnings report. Following the earnings report the stock price went up 3.753%.
Which hedge fund is a major shareholder of Brainsway?
Currently, no hedge funds are holding shares in IL:BWAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology